|
Match
|
Document |
Document Title |
|
|
6106861 |
Multiparticulate tablet disintegrating in less than 40 seconds in the mouth
The invention relates to a rapidly disintegratable multiparticulate tablet which disintegrates in the mouth in less than 40 seconds and which comprises an excipient and an active ingredient in the...
|
|
|
6103263 |
Delayed pulse release hydrogel matrix tablet
The invention provides a delayed-pulse controlled release pharmaceutical tablet having: (a) from 20 to 60 wt. % of a low molecular weight hydroxypropyl cellulose having a number average...
|
|
|
6103264 |
Process for preparing a controlled release composition
A process for preparing a controlled release composition with a controlled release matrix and containing a pharmaceutically active ingredient, which comprises granulating the active ingredient with...
|
|
|
6103260 |
Simethicone/anhydrous calcium phosphate compositions
The invention relates to antifoam oral solid dosage form preparations formed from a free flowing granular composition comprising an admixture of simethicone and either one or both of granular...
|
|
|
6099861 |
Disinfectant effervescent tablet formulation
A water soluble effervescent tablet formulation for preparing a disinfecting solution comprising a first tablet containing a bromide releasing agent and a second tablet containing a hypochlorite...
|
|
|
6099860 |
Controlled release oral preparation with naproxen sodium and pseudoephedrine
Pharmaceutical compositions comprising from about 50 mg to 500 mg of the non-steroidal anti-inflammatory analgesic naproxen and from about 15 mg to 120 mg of the decongestant pseudoephedrine are...
|
|
|
6086917 |
Tablet containing an enzymatically converted starch derivative encapsulating agent
The present invention is directed to a tablet, particularly a pharmaceutical dosage form, which contains an encapsulating agent comprising a modified starch which is prepared by enzymatic...
|
|
|
6086916 |
Progesterone tablet and its manufacturing process
The invention concerns a progesterone tablet characterised by the fact that its excipient content is at most 45%, preferably at most 40%, and yet more preferably at most 38%, the percentages being...
|
|
|
6086920 |
Disintegratable microspheres
Microspheres which disintegrate quickly in water are composed of bio-affecting agent(s), disintegrant(s) and spheronization aid(s). The microspheres, which may have taste-masking coatings, are...
|
|
|
6083527 |
Breath mint with tooth decay and halitosis prevention characteristics
A candy-like confection which contains a natural sweetener is provided. The confection preferably includes XYLITOL as the natural sweetener and calcium hydroxide which increases the pH level of the...
|
|
|
6080427 |
Cefadroxil monohydrate tablet formulation
This invention relates to uncoated direct compression tablets containing cefadroxil monohydrate as the active ingredient, which are capable of oral administration to human beings by swallowing,...
|
|
|
6077540 |
Gelatin spray coating
This invention provides a coating composition in which the principal film former is gelatin for use in coating tablets. The gelatin coating may be used with tablets, with or without any subcoating,...
|
|
|
6077535 |
Direct compression carbonyl iron tablet
This invention relates to a pharmaceutical composition for use as a direct compression tableting agent containing carbonyl iron and a process for making the same.
|
|
|
6068855 |
Pharmaceutical composition containing a fusible carrier and method for producing the same
A process for the manufacture of particles comprises mechanically working a mixture of a drug and a hydrophobic and/or hydrophilic fusible carrier in a high speed mixture so as to form...
|
|
|
6068859 |
Controlled-release dosage forms of Azithromycin
A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising...
|
|
|
6066337 |
Method for producing a rapidly dissolving dosage form
A particulate support matrix, and a dosage form made therefrom, and processes for making such support matrices and dosage forms, which disintegrate or dissolve in a matter of just a few seconds...
|
|
|
6066336 |
Cholesterol-lowering tablets
An improved cholesterol-lowering tablet is manufactured by blending tablet grade cholestyramine with an appropriate amount of lubricant and directly compressing into elongated tablets having a...
|
|
|
6066332 |
Immediate-effect ibuprofen-containing medicament and its use
|
|
|
6066334 |
Use of redispersible polymer powders or polymer granules as binders for producing solid pharmaceutical presentations
Redispersible polymer powders or polymer granules consisting of a) 10-95% by weight of polyvinyl acetate, b) 5-90% by weight of an N-vinylpyrrolidone-containing polymer, c) 0-20% by weight...
|
|
|
6063404 |
Bioadhesive tablet
This invention relates to a bioadhesive tablet containing at least one bioadhesive adjuvant and at least one lubricant, with at least one surface of the tablet comprising concentric or parallel,...
|
|
|
6063403 |
Compressed dry-granulation desogestrel tablets
Compressed dry-granulation tablets or granules comprising desogestrel and the method for making them comprising compressing a composition comprising desogestrel by applying elevated pressure,...
|
|
|
6057139 |
Preblend of microcrystalline cellulose and lactase for making tablets
A preblend for making lactase tablets is prepared containing about 1-99% (preferably about 20-60%) by weight lactase and about 1-99% (preferably about 40-80%) by weight microcrystalline cellulose....
|
|
|
6056975 |
Stabilized thyroid hormone preparations and methods of making same
Disclosed are thyroid hormone preparations useful in pharmaceutical applications. These preparations are disclosed to contain thyroxine drugs in combination with an inorganic salt, a carbohydrate...
|
|
|
6056974 |
Rapid-release S1452 tablets
The present invention provides a rapid-release tablet of S1452 at least containing the following components: a. a principal agent comprising (+)-(Z)-calcium...
|
|
|
6051253 |
Production of solid drug forms
Solid drug forms are produced by mixing and melting at least one pharmacologically acceptable polymeric binder and at least one pharmaceutical active ingredient, with or without conventional...
|
|
|
6051255 |
Polymer coated tablet comprising amoxycillin and clavulanate
The present invention is to a tablet formulation, being a medicament for oral administration for the treatment of bacterial infections, the tablet comprising a compacted mixture of 750-950 mg of...
|
|
|
6048541 |
Fast-dissolving comestible units formed under high-speed/high-pressure conditions
The invention relates to compositions useful for making tablets which can be formed using conventional tableting machines and which disintegrate rapidly in the mouth with optional chewing. The...
|
|
|
6048547 |
Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
Methods for the preparation of solid compositions are disclosed, where the composition comprises an active ingredient in association with polyethylene oxide and conventional additives, excluding...
|
|
|
6042839 |
Powder compositions
The present invention relates to cosmetic or pharmaceutical compositions comprising a powder containing a water soluble carboxylated gum and a clay crosslinked with metal ions.
|
|
|
6039980 |
Sustained release excipient
A sustained-release formulation for use in oral solid dosage forms includes from about 10 to about 40 percent or more by weight galactomannan gum; from about 1 to about 20 percent by weight of an...
|
|
|
6036974 |
Method and apparatus for preparation of molded tablet and thereby prepared molded tablet
Active ingredients such as medicines are mixed with excipient and then kneaded together with binder and solvent such as alcohol or water to prepare a wetted paste. A mold is filled with this paste....
|
|
|
6036975 |
Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
A rapid release tablet involves as an active ingredient tolfenamic acid or its pharmaceutically acceptable salts having a mean particle size of <10 μm, alginic acid or its pharmaceutically...
|
|
|
6030643 |
Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
Pharmaceutical compositions containing potassium, sodium or Tris salt of oxaprozin as an active agent. The pharmaceutical compositions of the present invention are useful in eliminating or...
|
|
|
6020001 |
Compositions for treating migraine
A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulph
onamide or a pharmaceutically...
|
|
|
6020002 |
Delivery of controlled-release system(s)
The present invention is a method and a dosage unit for delivery of a controlled-release system. The dosage unit is a quick dissolve unit which can be prepared by mixing uncured shearform matrix...
|
|
|
6015578 |
Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators
|
|
|
6013281 |
Method of making a pharmaceutical dosage form comprising a proton pump inhibitor
A new oral pharmaceutical dosage form comprising a core material that contains a proton pump inhibitor, one or more alkaline reacting compounds and optionally pharmaceutical excipients having a...
|
|
|
6010719 |
Freeze-dried disintegrating tablets
Freeze-dried disintegrating tablets, said tablets containing at least a therapeutic agent, a matrix forming agent and a binding agent, in which the tablets contain more than 20% by weight of a...
|
|
|
6010717 |
Starch products as tabletting excipient, method for preparing same, and method for making tablets
The invention relates to a tabletting excipient based on disintegrated starch granules, which is characterized by a content of long-chain amylose of at least 10% by weight based on the dry...
|
|
|
6008187 |
Peptide formulation
The present invention is directed to a pharmaceutical formulation of a therapeutic polypeptide together with a permeation-enhancing mixture of sodium salicylate and an oil to provide enhanced...
|
|
|
6004558 |
Methods for treating cancer with legume plant extracts
The present invention relates to the preparation of therapeutic compositions comprising extracts of leguminous plants from which the isoflavones genistein, daidzein, formononetin and biochanin...
|
|
|
6004996 |
Tetrahydrolipstatin containing compositions
Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0.25 to 2 mm; and...
|
|
|
6001391 |
Process for producing solid drug forms having at least two phases
A process for producing solid combination tablets which have at least two phases comprises molding a melt of a polymeric binder with or without at least one active ingredient, there being at least...
|
|
|
5998431 |
Sustained-release matrices for dental application
A sustained-release matrix for dental application includes either an anti-microbial agent or a colorant that is released from the matrix when the matrix contacts water. The preferred matrices...
|
|
|
5993860 |
NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
An oral-delivery pharmaceutical composition for reducing the gastric irritation effect of an NSAID in the upper GI tract of a mammal. The composition includes (a) a mucosal protective amount of a...
|
|
|
5989583 |
Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability
Lipophilic substances of poor oral bioavailability are mixed with at least one solid fat and phospholipid to obtain a dried solid composition suitable as an oral dosage form. The solid lipid...
|
|
|
5989578 |
Associations of active principles containing clopidogrel and an antithrombotic agent
The invention relates to a pharmaceutical composition containing an association of active principles, wherein the active principles are clopidogrel and aspirin, each constituent being present in a...
|
|
|
5989589 |
Cross-linked cellulose as a tablet excipient
Cross-linked cellulose is an excellent binder disintegrant that can be used in the preparation of pharmaceutical tablets. The tablets that are so prepared are made of a compressed mixture of a...
|
|
|
5989588 |
Methods and compositions for preventing and treating heartburn
A method for preventing heartburn episodes in a patient at risk to development of heartburn, comprising administering to the patient, following the heartburn inducing event but prior to development...
|
|
|
5990058 |
Hair hygiene product or hair treatment product for man or animals
A single-dose solid composition useful for cleaning or treating human or animal hair and having a high disintegration rate in water is disclosed. The composition includes at least one surface...
|